1-5 of 5
Pamela Bunner, BS
Close
Sort by
Journal Articles

Immunomodulation of Both Donors and Recipients with Atorvastatin As a Strategy for the Prevention of Acute Graft-Versus-Host Disease (aGVHD): Results of Two Parallel Prospective Trials in Recipients of Matched Sibling Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Mehdi Hamadani, MD, Michael Craig, MD, Scot Remick, MD, FACP, Laura Gibson, PhD, William Petros, Jame Abraham, MD, FACP, Aaron Cumpston, PharmD, Pamela Bunner, BS, Soumit Basu, MD, William Tse, MD, Carrie Hennelly, Sumithira Vasu, MBBS, Rebecca B Klisovic, MD, William Blum, MD, Samantha M. Jaglowski, MD, MPH, Don M. Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Sam Penza, MD, Craig C. Hofmeister, MD, Susan Geyer, PhD, Steven M. Devine, MD, Yvonne A Efebera, M.D.
Journal: Blood
Blood (2012) 120 (21): 1942.
https://doi.org/10.1182/blood.V120.21.1942.1942
Published: 2012
Journal Articles

Intermediate- Versus Low-Dose Cyclophosphamide and Granulocyte Colony Stimulating Factor for Peripheral Blood Progenitor Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Chemotherapies – A Multicenter Analysis

Sayed Mehdi Hamadani, MD, Thomas Samith Kochuparambil, Salman Osman, MD, Ethan Speir, Michael Craig, MD, David Deremer, Aaron Cumpston, PharmD, Devi D Morrison, Sonia Leadmon, BS, Kristen Sterling, Pamela Bunner, BS, Meghan Sterrett, Vamsi Kota, MBBS, Anand P. Jillella, MD, Farrukh T Awan, MD, MS
Journal: Blood
Blood (2011) 118 (21): 313.
https://doi.org/10.1182/blood.V118.21.313.313
Published: 2011
Journal Articles

Response to Induction Chemotherapy with Novel Agents Does Not Predict Outcomes of Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Salman Osman, MD, Abraham Sebastian Kanate, MD, Pamela Bunner, BS, Sonia Leadmon, BS, William Tse, Aaron Cumpston, PharmD, Laura Gibson, PhD, Scot Remick, MD, FACP, Jame Abraham, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 1347.
https://doi.org/10.1182/blood.V116.21.1347.1347
Published: 2010
Journal Articles

Higher Infused CD34+ Cell Dose Improves Survival In Patients Undergoing In Vivo T-Cell Depleted, but Not T-Cell Replete Peripheral Blood Hematopoietic Cell Transplant

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Kathy Watkins, MT, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 1272.
https://doi.org/10.1182/blood.V116.21.1272.1272
Published: 2010
Journal Articles

In Vivo T-Cell Depletion Does Not Improve Rates of Graft-Versus-Host Disease and Transplantation Outcomes In Patients Undergoing Peripheral Blood Hematopoietic Cell Transplant.

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 4536.
https://doi.org/10.1182/blood.V116.21.4536.4536
Published: 2010